Haven't used RNAimmune yet?
Ask Trustburn

Ask Trustburn about RNAimmune

Based on 10 reviews on Trustburn

Based on reviews on this page. Verify anything important with the company directly.

Joaquin Toribio
Reviews 1

RNAimmune is a great company to work for. Their website rnaimmune.com is user-friendly and informative. The team is knowledgeable and supportive, making it a pleasant working environment. The rate of their service is excellent, and I highly recommend them.

Mireille Suchanek
Reviews 1

I recently interacted with a company in the field of immunotherapy, and I must say, they impressed me. Their website is informative, and their service is top-notch. I had a great experience and would highly recommend them.

Questions & Answers

No questions yet β€” be the first to ask.

News & Press

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying widget on your website β€” its a simple way to convert your visitors into customers.

Embed code

<script src="https://trustburn.com/widgets/index.js"></script>
<div class="trustburn-widget" data-trustburn-protocol="https:" data-trustburn-domain="trustburn.com" data-trustburn-widget="score" data-company-path="rnaimmune-com" data-lang="en"></div>
More widgets

About RNAimmune

RNAimmune is a biopharmaceutical company specializing in the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. The company leverages mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a wide range of diseases. RNAimmune is a spin-off venture from Sirnaomics, Inc. has received a global exclusive right to the proprietary Polypeptide Lipid Nanoparticle (PLNP) technology for mRNA delivery from Sirnaomics. The company has also developed a proprietary A.I. algorithm (ALEPVA) for antigen prediction and vaccine design. By integrating multiple established platform technologies, the company is aiming to develop a comprehensive mRNA drug discovery and development platform, from which the company will enrich its therapeutic and vaccine product pipeline addressing tremendous unmet needs in treatments of viral infections, cancer, and rare diseases.